Treatment of patients (pts) with chronic myeloid leukemia (CML) and imatinib failure after developing Bcr-Abl kinase mutations with allogeneic stem cell transplantation (ASCT)

被引：0
|
作者：
Jabbour, E [1 ]
Cortes, J [1 ]
De Lima, M [1 ]
Andersson, B [1 ]
Giralt, S [1 ]
Kantarjian, H [1 ]
Champlin, R [1 ]
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2006年 / 12卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2005.11.058
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
43
引用
收藏
页码：18 / 18
页数：1
相关论文
共 50 条
  • [31] BCR-ABL Kinase Domain Mutations Exist in Few Imatinib Treated Chronic Myeloid Leukemia (CML) Patients Exhibiting Stable Cytogenetic and Hematologic Responses
    Akram, Afia Muhammad
    Akhtar, Tanveer
    Chaudhary, Asma
    Shahzad, Muhammad Mudassar
    Khalid, Ahmad Mukhtar
    Sajid, Nadia
    Sabar, Muhammad Farooq
    Iqbal, Zafar
    BLOOD, 2018, 132
  • [32] Incidence of Bcr-Abl kinase domain mutations in imatinib refractory chronic myeloid leukemia patients from South India
    Kagita, Sailaja
    Uppalapati, Srihari
    Jiwatani, Sangeeta
    Linga, Vijay Gandhi
    Gundeti, Sadasivudu
    Nagesh, Narayana
    Digumarti, Raghunadharao
    TUMOR BIOLOGY, 2014, 35 (07) : 7187 - 7193
  • [33] Characteristics of BCR-ABL kinase domain point mutations in Chinese imatinib-resistant chronic myeloid leukemia patients
    Qin, YaZhen
    Chen, ShanShan
    Jiang, Bin
    Jiang, Qian
    Jiang, Hao
    Li, JinLan
    Li, LingDi
    Lai, YueYun
    Liu, YanRong
    Huang, XiaoJun
    ANNALS OF HEMATOLOGY, 2011, 90 (01) : 47 - 52
  • [34] BCR- ABL KINASE MUTATIONS TO IMATINIB RESISTANCE IN CHRONIC MYELOID LEUKEMIA
    Thungappa, S. Chiradoni
    Singh, T.
    Rashmi, N. R.
    Lokanatha, D.
    Rajshekar, H.
    Lakshmaiah, K. C.
    Babu, K. G.
    Suresh, T. M.
    ANNALS OF ONCOLOGY, 2010, 21 : 357 - 357
  • [35] Response to Imatinib Treatment in Chronic Myeloid Leukemia According to BCR-ABL Transcript
    Acosta Hernandez, Titania del Carmen
    Best Aguilera, Carlos Roberto
    Villela Martinez, Luis Mario
    Guzman Hernandez, Alicia Elizabeth
    Robles Rodriguez, Arianna
    Lopez Hernandez, Juan Carlos
    Gomez Vazquez, Oscar Rodrigo
    Rivera Mendoza, Laura Adriana
    Garcia Reyes, Barbara
    Gutierrez Alatorre, Aldo Fernando Adrian
    Calderon Valdez, Areli Sarai
    Visuetti Pimentel, Saribethe Mahely
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S242 - S243
  • [36] Consecutive but not isolated BCR-ABL transcript level rises are predictive of BCR-ABL kinase mutations in chronic myeloid leukaemia patients treated by imatinib
    Clark, RE
    Knight, K
    Lucas, CM
    Wang, L
    EXPERIMENTAL HEMATOLOGY, 2005, 33 (07) : 52 - 52
  • [37] BCR-ABL kinase domain mutations in chronic myeloid leukemia - Not quite enough to cause resistance to imatinib therapy?
    Lange, T
    Park, B
    Willis, SG
    Deininger, MWN
    CELL CYCLE, 2005, 4 (12) : 1761 - 1766
  • [38] Evaluation of BCR-ABL/ABL Ratio Increase That Corresponds to BCR-ABL Mutation In Chronic Myeloid Leukemia Patients Treated by Imatinib
    Tsaur, Grigory
    Ivanova, Anna
    Popov, Alexander
    Yakovleva, Yulia
    Riger, Tatyana
    Plekhanova, Olga
    Ivanets, Yulia
    Misyurin, Andrey
    Suchkova, Marina
    Shorikov, Egor
    Saveliev, Leonid
    Fechina, Larisa
    BLOOD, 2010, 116 (21) : 1402 - 1402
  • [39] Lack of Bcr-Abl point mutations in chronic myeloid leukemia patients in chronic phase before imatinib treatment is not predictive of response
    Agirre, X
    Fontalba, A
    Andreu, EJ
    Odero, MD
    Larróyoz, MJ
    Montiel, C
    Calasanz, M
    Fernández-Luna, JL
    Prósper, F
    HAEMATOLOGICA, 2003, 88 (12) : 1425 - 1426
  • [40] IMPACT OF BCR-ABL MUTATIONS ON RESPONSE TO DASATINIB IN ELDERLY CHRONIC MYELOID LEUKEMIA PATIENTS RESISTANT TO IMATINIB
    Tiribelli, M.
    Latagliata, R.
    Breccia, M.
    Luciano, L.
    Castagnetti, F.
    Gozzini, A.
    Cambrin, G. Rege
    Annunziata, M.
    Stagno, F.
    Pregno, P.
    Albano, F.
    Abruzzese, F.
    Musto, P.
    Sora, F.
    Ferrero, D.
    Montefusco, E.
    Cavazzini, F.
    Binotto, G.
    Fanin, R.
    Pane, F.
    Rosti, G.
    Santini, V.
    Fava, C.
    Alimena, G.
    Vigneri, P.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 347 - 347
12345